Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS)

Cancer science Volume 113 Issue 9 Page 3169-3179 published_at 2022-07-23
アクセス数 : 611
ダウンロード数 : 0

今月のアクセス数 : 0
今月のダウンロード数 : 0
Title
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS)
Creator
Yutaka Yamamoto 1, Hiroji Iwata 2, Naruto Taira 3, Norikazu Masuda 4, Masato Takahashi 5, Tetsuhiro Yoshinami 6 7, Takayuki Ueno 8, Tatsuya Toyama 9, Takashi Yamanaka 10, Toshimi Takano 11 12, Masahiro Kashiwaba 13 14, Koichiro Tsugawa 15, Yoshie Hasegawa 16, Kenji Tamura 17 18, Hiroshi Tada 19, Fumikata Hara 12 20, Tomomi Fujisawa 21, Naoki Niikura 22, Shigehira Saji 23, Satoshi Morita 24, Masakazu Toi 25, Shinji Ohno 26
Source Title
Cancer science
Volume 113
Issue 9
Start Page 3169
End Page 3179
Journal Identifire
ISSN 1347-9032
EISSN 1349-7006
Language
eng
Resource Type journal article
Publisher
John Wiley & Sons
Date of Issued 2022-07-23
権利関係(リンク)

This work is licensed under CC BY-NC-ND 4.0

Access Rights metadata only access
Relation
[DOI] 10.1111/cas.15474
[PMID] 35754298